Outcomes of Stage IVA Cervical Cancer Treated with Radiation Therapy: A Systematic Review and Meta-Analysis.
Surendra Kumar Saini, Shelly Srivastava, Anil Goel et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated survival outcomes and treatment-related morbidity in 492 patients with stage IVA cervical cancer treated with definitive radiotherapy. The study found 5-year disease-free and overall survival rates of 30.9% and 34.8%, respectively. The analysis highlighted the importance of concurrent chemoradiation and brachytherapy for improved outcomes.
Key findings
- 5-year disease-free survival rate was 30.9% (95% CI, 16.0-45.8).
- 5-year overall survival rate was 34.8% (95% CI, 26.4-43.3).
- Pooled incidence of treatment-related fistula was 23.7% (95% CI, 12.9-34.6).
- Concurrent chemoradiation and completion of brachytherapy were linked to better outcomes.
Why it matters
The findings underscore the challenges in managing stage IVA cervical cancer, highlighting the need for effective treatment strategies to improve survival and minimize morbidity. Understanding these outcomes can guide clinicians in treatment planning and patient counseling.